Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extraskeletal Osteosarcoma of the Hand in an Adolescent: A Case Report.
Bellan DG, Jesus-Garcia R, Teresa de Seixas Alves M, Petrilli MT, Petrilli AS, Korukian M, Carai Maia Viola D, Schoedl MF, Senerchia AA. Bellan DG, et al. JBJS Case Connect. 2013 Jan-Mar;3(1):e6. doi: 10.2106/JBJS.CC.L.00004. JBJS Case Connect. 2013. PMID: 29252311 No abstract available.
Epiphyseal plate involvement in osteosarcoma.
Jesus-Garcia R, Seixas MT, Costa SR, Petrilli AS, Laredo Filho J. Jesus-Garcia R, et al. Clin Orthop Relat Res. 2000 Apr;(373):32-8. doi: 10.1097/00003086-200004000-00006. Clin Orthop Relat Res. 2000. PMID: 10810460
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.
Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, Camargo OP, Pena W, Péricles P, Davi A, Prospero JD, Alves MT, Oliveira CR, Macedo CR, Mendes WL, Almeida MT, Borsato ML, dos Santos TM, Ortega J, Consentino E; Brazilian Osteosarcoma Treatment Group Studies III and IV. Petrilli AS, et al. J Clin Oncol. 2006 Mar 1;24(7):1161-8. doi: 10.1200/JCO.2005.03.5352. J Clin Oncol. 2006. PMID: 16505436 Clinical Trial.
Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30.
Cramarossa G, Zeng L, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Sahgal A, Lam H, Pulenzas N, Chow E. Cramarossa G, et al. Among authors: jesus garcia r. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):139-46. doi: 10.1586/14737167.2014.864560. Epub 2013 Dec 10. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24325545
International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bottomley A; European Organization for Research Treatment of Cancer Quality of Life Group. Chow E, et al. Cancer. 2012 Mar 1;118(5):1457-65. doi: 10.1002/cncr.26410. Epub 2011 Aug 11. Cancer. 2012. PMID: 21837676 Free article.
An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
Zeng L, Chow E, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bedard G, Bottomley A. Zeng L, et al. Support Care Cancer. 2012 Dec;20(12):3307-13. doi: 10.1007/s00520-012-1484-x. Epub 2012 May 6. Support Care Cancer. 2012. PMID: 22562607
19 results